Evaluation of an automated extraction system in combination with Affigene® CMV Trender for CMV DNA quantitative determination: Comparison with nested PCR and pp65 antigen test

Journal of Virological Methods

Volumn 151, Issue 1, 2008, Pages 61-65

  Abbate, I ^a   Finnstrom, N ^b   Zaniratti, S ^a   Solmone, M C ^a   Selvaggini, S ^c   Bennici, E ^a   Neri, S ^a   Brega, C ^a   Paterno, M ^a   Capobianchi, M R ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Cepheid AB   (Sweden)

^c Alfa Wassermann Diagnostics   (Italy)

Author keywords

CMV; Nucleic acid extraction; Viral load

Indexed keywords

VIRUS DNA;

ARTICLE; CYTOMEGALOVIRUS; DNA EXTRACTION; EVALUATION; FEMALE; HUMAN; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; VIRUS LOAD;

AUTOMATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIRAL MATRIX PROTEINS;

EID: 44649140423     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.03.021     Document Type: Article

References (23)

1. Allice T., Enrietto M., Pittaluga F., Varetto S., Franchello A., Marchiaro G., and Ghisetti V. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J. Med. Virol. 78 (2006) 915-922
2. Boeckh M., Gallez-Hawkins G.M., Myerson D., Zaia J.A., and Bowden R.A. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 64 (1997) 108-113
3. Boeckh M., Nichols W.G., Papanicolaou G., Rubin R., Wingard J.R., and Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol. Blood Marrow Transplant. 9 (2003) 543-558
4. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., and Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355 (2000) 2032-2036
5. Emery V.C. Investigation of CMV disease in immunocompromised patients. J. Clin. Pathol. 54 (2001) 84-88
6. Gerna G., Lilleri D., Zecca M., Alessandrino E.P., Baldanti F., Revello M.G., and Locatelli F. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Haematologica 90 (2005) 526-533
7. Gerna G., Baldanti F., Torsellini M., Minoli L., Vigano M., Oggionnis T., Rampino T., Castiglioni B., Goglio A., Colledan M., Mammana C., Nozza F., Lilleri D., and and the Bergamo Transplant Group. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study. Antivir. Ther. 12 (2007) 63-72
8. Hernando S., Folgueira L., Lumbreras C., San Juan R., Maldonado S., Prieto C., Babiano M.J., Delgado J., Andres A., Moreno E., Aguado J.M., and Otero J.R. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant. Proc. 37 (2005) 4094-4096
9. Hornef M.W., Bein G., Fricke L., Steinhoff J., Wagner H.J., Hinderer W., Sonneborn H.H., and Kirchner H. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 60 (1995) 474-480
10. Kalpoe J.S., Kroes A.C., de Jong M.D., Schinkel J., de Brouwer C.S., Beersma M.F., and Claas E.C. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J. Clin. Microbiol. 42 (2004) 1498-1504
11. Lautenschlager I. Cytomegalovirus and solid organ transplantation: an update. Curr. Opin. Organ Transplant. 8 (2003) 269-275
12. Lilleri D., Baldanti F., Gatti M., Rovida F., Dossena L., De Grazia S., Torsellini M., and Gerna G. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J. Med. Virol. 73 (2004) 412-418
13. Lilleri D., Gerna G., Furione M., Bernardo M.E., Giorgiani G., Telli S., Baldanti F., and Locatelli F. Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of pre-emptively treated children and young adults receiving haematopoietic stem cell transplantation as compared to qualitative pp65-antigenemia. Blood 110 (2007) 2757-2760
14. Martin-Davila P., Fortun J., Gutierrez C., Marti-Belda P., Candelas A., Honrubia A., Barcena R., Martinez A., Puente A., de Vicente E., and Moreno S. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J. Clin. Virol. 33 (2005) 138-144
15. Mengelle C., Sandres-Saune K., Pasquier C., Rostaing L., Mansuy J.M., Marty M., Da Silva I., Attal M., Massip P., and Izopet J. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J. Clin. Microbiol. 41 (2003) 3840-3845
16. Mengoli C., Cusinato R., Biasolo M.A., Cesaro S., Parolin C., and Palu G. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J. Med. Virol. 74 (2004) 78-84
17. Piiparinen H., Hockerstedt K., Gronhagen-Riska C., and Lautenschlager I. Comparison of two quantitative CMV PCR test, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J. Clin. Virol. 30 (2004) 258-266
18. Piiparinen H., and Lautenschlager I. Quantitative TaqMan assay for the detection and monitoring of cytomegalovirus infection in organ transplant patients. Methods Mol. Biol. 335 (2006) 147-156
19. Razonable R.R., Brown R.A., Wilson J., Groettum C., Kremers W., Espy M., Smith T.F., and Paya C.V. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 73 (2002) 968-973
20. Razonable R.R., and Emery V.C. Management of CMV infection and disease in transplant patients. Proceedings of the 11th Annual Meeting of the IHMF (International Herpes Management Forum). Herpes 11 (2004) 77-86
21. Sassenscheidt J., Rohayem J., Illmer T., and Bandt D. Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR. J. Virol. Methods 138 (2006) 40-48
22. Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., and Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72 (1991) 2059-2064
23. Von Muller L., Hinz J., Bommer M., Hampl W., Kluwick S., Wiedmann M., Bunjes D., and Mertens T. CMV monitoring using blood cells and plasma: a comparison of apples with oranges?. Bone Marrow Transplant. 39 (2007) 353-357